1-5 of 5
Ellen K. Ritchie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hematopoietic fitness of JAK2 V617F myeloproliferative neoplasms is linked to clinical outcome

Ghaith Abu-Zeinah, Silvana Di Giandomenico, Daniel Choi, Tatiana Cruz, Katie Erdos, Elwood Taylor, III, Ellen K. Ritchie, Richard T. Silver, Joseph M. Scandura
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5477–5481.
https://doi.org/10.1182/bloodadvances.2022007128
Published: 2022
Includes: Supplemental data
Journal Articles

Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101

Ellen K. Ritchie, Heidi D. Klepin, Elizabeth Storrick, Brittny Major, Jennifer Le-Rademacher, Martha Wadleigh, Alison Walker, Richard A. Larson, Gail J. Roboz
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3812–3820.
https://doi.org/10.1182/bloodadvances.2021006872
Published: 2022
Includes: Supplemental data
Journal Articles

Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response

Clinical Trials & Observations
Ok-kyong Chaekal, Andromachi Scaradavou, Emeline Masson Frenet, Maria S. Albano, Melissa Cushing, Pinkal Desai, Ludy Dobrila, Usama Gergis, Danielle Guarneri, Jing-Mei Hsu, Sangmin Lee, Sebastian A. Mayer, Adrienne A. Phillips, Nina Orfali, Ellen K. Ritchie, Gail J. Roboz, Cynthia Romeo, Michael S. Samuel, Tsiporah Shore, Koen van Besien
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5146–5156.
https://doi.org/10.1182/bloodadvances.2020002805
Published: 2020
Includes: Supplemental data
Journal Articles

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Clinical Trials & Observations
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, Judith Neukirchen, Mikkael A. Sekeres, Andrew M. Brunner, Gail J. Roboz, David P. Steensma, Vijaya R. Bhatt, Uwe Platzbecker, Thomas Cluzeau, Pedro H. Prata, Raphaël Itzykson, Pierre Fenaux, Amir T. Fathi, Alexandra Smith, Ulrich Germing, Ellen K. Ritchie, Vivek Verma, Aziz Nazha, Jaroslaw P. Maciejewski, Nikolai A. Podoltsev, Thomas Prebet, Valeria Santini, Steven D. Gore, Rami S. Komrokji, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1765–1772.
https://doi.org/10.1182/bloodadvances.2018019414
Published: 2018
Journal Articles

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Clinical Trials & Observations
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, Raphael Itzykson, Ellen K. Ritchie, Mikkael A. Sekeres, John D. Barnard, Nikolai A. Podoltsev, Andrew M. Brunner, Rami S. Komrokji, Vijaya R. Bhatt, Aref Al-Kali, Thomas Cluzeau, Valeria Santini, Amir T. Fathi, Gail J. Roboz, Pierre Fenaux, Mark R. Litzow, Sarah Perreault, Tae Kon Kim, Thomas Prebet, Norbert Vey, Vivek Verma, Ulrich Germing, Juan Miguel Bergua, Josefina Serrano, Steven D. Gore, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2018) 2 (8): 923–932.
https://doi.org/10.1182/bloodadvances.2018016121
Published: 2018
Includes: Supplemental data